Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 19 of 25
Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women
NCT01147497
Melatonin and Nighttime Blood Pressure in African Americans--24 mg Study
NCT01114373
Alteration in Timing of Plerixafor Administration
NCT01149863
Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer
NCT01194869
Compassion Meditation and ReliefLink App for Suicidal, Low-Income, African Americans
NCT03463980
Diabetes in the Elderly: Retrospective Study
NCT01104168
Prevention of Cystic Fibrosis Diabetes
NCT00967798
A Culturally Tailored Lifestyle Intervention to Prevent Diabetes in South Asians
NCT01084928
Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients
NCT01027897
The Health Outcomes Management and Evaluation (HOME) Study
NCT01228032
Melatonin and Nighttime Blood Pressure in African Americans-8 mg Study
NCT01114360
Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck
NCT01116336
Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection
NCT01095757
A Web-based Bystander Education Program
NCT01903876
Glutamine Supplementation in Cystic Fibrosis
NCT01051999
Pilot Study Assessing Oxidative Stress in Children
NCT01052207
Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Plaques
NCT01230892
A Study of the Combination Vorinostat With Lenalidomide, Bortezomib and Dexamethasone for Patients With Newly Diagnosed Multiple Myeloma
NCT01038388
Caregiver Stress: Interventions to Promote Health and Wellbeing
NCT01188070
A Pilot Study of Thrombin Generation Changes in Neonates Undergoing Placement of a Blalock-Taussig Shunt
NCT01340378
Trial on Safety and Pharmacokinetics of Intravaginal Curcumin
NCT01035580
TT-CMV Observational Birth Cohort Study
NCT00907686
Quetiapine XR for Cognitive and Functional Disability in Clinically Stable Patients With Bipolar Disorder
NCT00746421
Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells
NCT01041287
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
NCT01018992
The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension
NCT01049009
Study of the Function of Cells Involved in Inflammation in the Lungs of Those With Acute Lung Injury and Sepsis
NCT01725061
Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
NCT00965198
Diabetes Group Visits
NCT01000363
Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT
NCT01941706
Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females
NCT00813319
Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer
NCT01271738
Cost Effectiveness and Quality of Life in Heart Failure Patients With Diabetes
NCT01606085
Granulocyte-Macrophage Stimulating Factor in the Treatment of Peripheral Arterial Disease
NCT01041417
Surgical Planning for Reconstruction of Complex Heart Defects
NCT00972608
Magnetic Resonance Imaging (MRI) to Evaluate Brain Injury in Congenital Heart Disease
NCT00932633
Exemestane or Docetaxel-Cytoxan in Low Recurrence Score Cancers
NCT00941330
Thiazolidinediones (TZD) Bone Loss and the Effects on Bone Marrow Differentiation and Osteoblast Formation
NCT00663143
Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)
NCT02406586
Melatonin and the Metabolic Syndrome
NCT01038921
Chemotherapy Monitoring With Breast Computed Tomography (CT)
NCT00808041
Neural Circuits in Women With Abuse and Posttraumatic Stress Disorder
NCT01681849
Comparison Study of Breast Computed Tomography (CT) With Magnetic Resonance Imaging (MRI)
NCT00957099
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
NCT01526486
Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis
NCT01188083
An Evaluation of Psychological Parameters That May Influence the Outcome Following Arthroscopy and Arthroplasty for Temporomandibular Joint Surgery
NCT01396694
Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer
NCT00912340
Breast Computed Tomography (CT) as a Diagnostic Tool
NCT00957307
Amino Acid Tracer (FACBC) Positron Emission Tomography for Lung Nodule
NCT01502670
FFA Hypertension and Inflammation in Lean and Obese Subjects
NCT00721617
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Emory University pipeline card: 1,208 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.